BIRMINGHAM, Ala. (AP) - Flu drug developer BioCryst Pharmaceuticals Inc. priced its 5 million common stock share offering at $9.75 per share. On Thursday after the markets closed the company estimated gross proceeds of $48.8 million. The banks ...
view
Friday, November 20, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.